✦ LIBER ✦

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer

✍ Scribed by Zumre A. Alicikus; Yoshiya Yamada; Zhigang Zhang; Xin Pei; Margie Hunt; Marisa Kollmeier; Brett Cox; Michael J. Zelefsky

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 391 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25467

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation dose escalation for localized

Radiation dose escalation for localized prostate cancer : Intensity-modulated radiotherapy versus permanent transperineal brachytherapy

✍ William W. Wong; Sujay A. Vora; Steven E. Schild; Gary A. Ezzell; Paul E. Andrew 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

## Abstract ## BACKGROUND: In the current study, the effects of dose escalation for localized prostate cancer treatment with intensity‐modulated radiotherapy (IMRT) or permanent transperineal brachytherapy (BRT) in comparison with conventional dose 3‐dimensional conformal radiotherapy (3D‐CRT) wer

Intensity-modulated radiotherapy for loc

Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx

✍ Megan E. Daly; Quynh-Thu Le; Anshu K. Jain; Peter G. Maxim; Annie Hsu; Billy W. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract ## Background Limited data evaluate intensity‐modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients. ## Methods Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (S

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views

Erratum: Comparative risk-adjusted morta

Erratum: Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

The impact of conventional plus high dos

The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer

✍ Lawrence B. Marks; Gary L. Rosner; Leonard R. Prosnitz; Maureen Ross; James J. V 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Ten-year follow-up of a phase 2 study of

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer

✍ Gisele A. Sarosy; Mahrukh M. Hussain; Michael V. Seiden; Arlan F. Fuller; Najmos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: The objective of this study was to assess activity and toxicity in patients with newly diagnosed, advanced‐stage epithelial ovarian cancer (EOC) who were receiving dose‐intense paclitaxel, cyclophosphamide, cisplatin, and filgrastim delivered with a flexible dosing sched